Erythropoietin protects myocardin-expressing cardiac stem cells against cytotoxicity of tumor necrosis factor-α

This publication has 28 references indexed in Scilit:

• iNOS in cardiac myocytes plays a critical role in death in a murine model of hypertrophy induced by calcineurin
  American Journal of Physiology-Heart and Circulatory Physiology, 2008
• Myocardin A Enhances Telomerase Activities in Adipose Tissue Mesenchymal Cells and Embryonic Stem Cells Undergoing Cardiovascular Myogenic Differentiation
  The International Journal of Cell Cloning, 2007
• Tumor necrosis factor-α in mechanic trauma plasma mediates cardiomyocyte apoptosis
  American Journal of Physiology-Heart and Circulatory Physiology, 2007
• TNFα-initiated oxidative/nitrative stress mediates cardiomyocyte apoptosis in traumatic animals
  Apoptosis, 2007
• Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities
  Proceedings of the National Academy of Sciences, 2006
• Myocardin Expression Is Regulated by Nkx2.5, and Its Function Is Required for Cardiomyogenesis
  Molecular and Cellular Biology, 2003
• Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
  The Lancet, 2003
• Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion Injury
  Circulation, 2003
• The effect of erythropoietin on interleukin-1β mediated increase in nitric oxide synthesis in vascular smooth muscle cells
  Journal Of Hypertension, 1999
• Human recombinant erythropoietin inhibits interleukin-1 -stimulated nitric oxide and cyclic guanosine monophosphate production in cultured rat vascular smooth-muscle cells
  Nephrology Dialysis Transplantation, 1999